The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes

Journal of Experimental Medicine

Volumn 186, Issue 2, 1997, Pages 199-207

  Martin, Ulrich ^a   Bock, Daniel ^a   Arseniev, Lubomir ^b   Tornetta, Mark A ^c   Ames, Robert S ^c   Bautsch, Wilfried ^a   Köhl, Jörg ^a   Ganser, Arnold ^b   Klos, Andreas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Dept of Hematology and Oncology ^*  (Germany)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BINDING COMPETITION; CELL SPECIFICITY; CELLULAR DISTRIBUTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONOCYTE; NEUTROPHIL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; BLOTTING, NORTHERN; CALCIUM; COMPLEMENT C3A; FLOW CYTOMETRY; HUMANS; MEMBRANE GLYCOPROTEINS; MONOCYTES; NEUTROPHILS; RABBITS; RATS; RECEPTORS, COMPLEMENT; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0030739649     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.2.199     Document Type: Article

References (33)

1. Köhl, J., and D. Bitter-Suermann. 1993. Anaphylatoxins. In Complement in Health and Disease. K. Whaley, M. Loos, and J.M. Weiler, editors. Kluwer Academic Publishers, Dordrecht, Germany. 295-320.
2. Bitter-Suermann, D. 1988. The anaphylatoxins. In The Complement System. K. Rother and G.O. Till, editors. Springer-Verlag, Berlin. 367-395.
3. Morgan, E.L. 1986. Modulation of the immune response by anaphylatoxins. Complement. 3:128-136.
4. Boulay, F., L. Mery, M. Tardif, L. Brouchon, and P. Vignais. 1991. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry. 30:2993-2999.
5. Gerard, N.P., and C. Gerard. 1991. The chemotactic receptor for human C5a anaphylatoxin. Nature (Lond.). 349:614-617.
6. Hopken, U.E., B. Lu, N.P. Gerard, and C. Gerard. 1996. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature (Lond.). 383:86-89.
7. Ames, R.S., Y. Li, H.M. Sarau, P. Nuthulaganti, J.J. Foley, C. Ellis, Z. Zeng, K. Su, A.J. Jurewicz, R.P. Hertzberg, D.J. Bergsma, and C. Kumar. 1996. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J. Biol. Chem. 271:20231-20234.
8. Crass, T., U. Raffetseder, U. Martin, M. Grove, A. Klos, J. Köhl, and W. Bautsch. 1996. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. Eur. J. Immunol. 26:1944-1950.
9. Roglić, A., E.R. Prossnitz, S.L. Cavanagh, Z. Pan, A. Zou, and R.D. Ye. 1996. cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure. Biochim. Biophys. Acta 1305:39-43.
10. Dahinden, C.A., S.C. Bischoff, T. Brunner, M. Krieger, S. Takafuji, and A.L. de Weck. 1991. Regulation of mediator release by human basophils: importance of the sequence and time of addition in the combined action of different agonists. Int. Arch. Allergy Appl. Immunol. 94:161-164.
11. Kretzschmar, T., A. Jeromin, C. Gietz, W. Bautsch, A. Klos, J. Köhl, G. Rechkemmer, and D. Bitter-Suermann. 1993. Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a. Eur. J. Immunol. 23:558-561.
12. Legler, D.F., M. Loetscher, S.A. Jones, C.A. Dahinden, M. Arock, and B. Moser. 1996. Expression of high-and low-affinity receptors for C3a on the human mast cell line, HMC-1. Eur. J. Immunol. 26:753-758.
13. Daffern, P.J., P.H. Pfeifer, J.A. Ember, and T.E. Hugli. 1995. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J. Exp. Med. 181:2119-2127.
14. Elsner, J., M. Oppermann, W. Czech, G. Dobos, E. Schopf, J. Norgauer, and A. Kapp. 1994. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils. Eur. J. Immunol. 24:518-522.
15. 125I-C3a binding. Biochemistry. 31:11274-11282.
16. Burg, M., U. Martin, D. Bock, C. Rheinheimer, J. Köhl, W. Bautsch, and A. Klos. 1996. Differential regulation of the C3a and C5a receptors (CD88) by IFN-gamma and PMA in U937 cells and related myeloblastic cell lines. J. Immunol. 157:5574-5581.
17. Takabayashi, T., E. Vannier, B.D. Clark, N.H. Margolis, C.A. Dinarello, J.F. Burke, and J.A. Gelfand. 1996. A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis. J. Immunol. 156:3455-3460.
18. Gerardy-Schahn, R., D. Ambrosius, D. Saunders, M. Casaretto, C. Mittler, G. Karwarth, S. Gorgen, and D. Bitter-Suermann. 1989. Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes. Eur. J Immunol 19:1095-1102.
19. Norgauer, J., G. Dobos, E. Kownatzki, C. Dahinden, R. Burger, R. Kupper, and P. Gierschik. 1993. Complement fragment C3a stimulates Ca2+ influx in neutrophils via a perfussis-toxin-sensitive G protein. Eur. J. Biochem. 217:289-294.
20. Ehrengruber, M.U., T. Geiser, and D.A. Deranleau. 1994. Activation of human neutrophils by C3a and C5A. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst. FEBS Lett. 346:181-184.
21. Van-Epps, D.E., and D.E. Chenoweth. 1984. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes. J. Immunol. 132:2862-2867.
22. Hansel, T.T., I.J. De Vries, T. Iff, S. Rihs, M. Wandzilak, S. Betz, K. Blaser, and C. Walker. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J. Immunol. Methods. 145:105-110.
23. Leucocyte Typing IV: White Cell Differentiation Antigens. 1989. Knapp, W., B. Dörken, W.R. Gilks, E.P. Rieber, R.E. Schmidt, H. Stein, and A.E.G.Kr. von dem Borne, editors. Oxford University Press, Oxford. 1182 pp.
24. Kimura, I., Y. Moritani, and Y. Tanizaki. 1973. Basophils in bronchial asthma with reference to reagin-type allergy. Clin. Allergy. 3:195-202.
25. Colotta, F., G. Peri, A. Villa, and A. Mantovani. 1984. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. J. Immunol. 132:936-944.
26. Brock, T.G., R.W. McNish, M.J. Coffey, T.C. Ojo, S.M. Phare, and M. Peters Golden. 1996. Effects of granulocyte-macrophage colony-stimulating factor on eicosanoid production by mononuclear phagocytes. J. Immunol. 156:2522-2527.
27. Fort, P., L. Marty, M. Piechaczyk, S. el Sabrouty, C. Dani, P. Jeanteur, and J.M. Blanchard. 1985. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1431-1442.
28. Hansel, T.T., J.B. Braunstein, C. Walker, K. Blaser, P.L. Bruijnzeel, J.C. Virchow, Jr., and C.S. Virchow. 1991. Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin. Exp. Immunol. 86:271-277.
29. Forsyth, K.D. 1991. Anti-CD9 antibodies augment neutrophil adherence to endothelium. Immunology. 72:292-296.
30. Saito, H., K. Yamada, J. Breard, O. Yoshie, and G. Mathe. 1986. A monoclonal antibody reactive with human eosinophils. Blood. 67:50-55.
31. Eisner, J., V. Kaever, A. Emmendorffer, T. Breidenbach, M.L. Lohmann Matthes, and J. Roesler. 1992. Heterogeneity in the mobilization of cytoplasmic calcium by human polymorphonuclear leukocytes in response to fMLP, C5a and IL-8/NAP-1. J. Leukocyte Biol. 51:77-83.
32. Butkerait, P., Y. Zheng, H. Hallak, T.E. Graham, H.A. Miller, K.D. Burris, P.B. Molinoff, and D.R. Manning. 1995. Expression of the human 5-hydroxytryptamine1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. J. Biol. Chem. 270: 18691-18699.
33. Raffetseder, U., D. Roper, L. Mery, C. Gietz, A. Klos, J. Grotzinger, A. Wollmer, F. Boulay, J. Köhl, and W. Bautsch. 1996. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor. Eur. J. Biochem. 235:82-90.